A metabolic labeling approach for glycoproteomic analysis reveals altered glycoprotein expression upon GALNT3 knockdown in ovarian cancer cells.

[1]  C. Bertozzi,et al.  Proteomic dataset for altered glycoprotein expression upon GALNT3 knockdown in ovarian cancer cells , 2016, Data in brief.

[2]  C. Bertozzi,et al.  Isotope Targeted Glycoproteomics (IsoTaG) to Characterize Intact, Metabolically Labeled Glycopeptides from Complex Proteomes , 2016, Current protocols in chemical biology.

[3]  Yohann Couté,et al.  Spiked proteomic standard dataset for testing label-free quantitative software and statistical methods , 2015, Data in brief.

[4]  C. Guillemette,et al.  BCAT1 expression associates with ovarian cancer progression: possible implications in altered disease metabolism , 2015, Oncotarget.

[5]  S. Pinho,et al.  Glycosylation in cancer: mechanisms and clinical implications , 2015, Nature Reviews Cancer.

[6]  I. Shih,et al.  Inhibition of Spleen Tyrosine Kinase Potentiates Paclitaxel-Induced Cytotoxicity in Ovarian Cancer Cells by Stabilizing Microtubules. , 2015, Cancer cell.

[7]  M. Werner,et al.  Metadherin exon 11 skipping variant enhances metastatic spread of ovarian cancer , 2015, International journal of cancer.

[8]  C. Bertozzi,et al.  Isotope-targeted glycoproteomics (IsoTaG): a mass-independent platform for intact N- and O-glycopeptide discovery and analysis , 2015, Nature Methods.

[9]  Tao Xi,et al.  Overexpression of astrocyte-elevated gene-1 is associated with ovarian cancer development and progression. , 2015, Molecular medicine reports.

[10]  Yang Zhang,et al.  A preliminary quantitative proteomic analysis of glioblastoma pseudoprogression , 2015, Proteome Science.

[11]  D. Bachvarov,et al.  Role of aberrant glycosylation in ovarian cancer dissemination , 2014 .

[12]  V. Piller,et al.  Changes in Metabolic Chemical Reporter Structure Yield a Selective Probe of O-GlcNAc Modification , 2014, Journal of the American Chemical Society.

[13]  M. Davidson,et al.  The cancer glycocalyx mechanically primes integrin-mediated growth and survival , 2014, Nature.

[14]  M. Anugraham,et al.  Specific Glycosylation of Membrane Proteins in Epithelial Ovarian Cancer Cell Lines: Glycan Structures Reflect Gene Expression and DNA Methylation Status * , 2014, Molecular & Cellular Proteomics.

[15]  Gen Sheng Wu,et al.  Role of Autophagy in Cisplatin Resistance in Ovarian Cancer Cells* , 2014, The Journal of Biological Chemistry.

[16]  Yu Qin,et al.  Astrocyte elevated gene-1: a novel independent prognostic biomarker for metastatic ovarian tumors , 2014, Tumor Biology.

[17]  Congjian Xu,et al.  Discovery of Specific Metastasis-Related N-Glycan Alterations in Epithelial Ovarian Cancer Based on Quantitative Glycomics , 2014, PloS one.

[18]  V. Mootha,et al.  Metabolic enzyme expression highlights a key role for MTHFD2 and the mitochondrial folate pathway in cancer , 2014, Nature Communications.

[19]  Hua Li,et al.  Identification of ribonucleotide reductase M2 as a potential target for pro-senescence therapy in epithelial ovarian cancer , 2014, Cell cycle.

[20]  D. Bachvarov,et al.  Role of the polypeptide N-acetylgalactosaminyltransferase 3 in ovarian cancer progression: possible implications in abnormal mucin O-glycosylation , 2014, Oncotarget.

[21]  Mingjun Wu,et al.  The mucin-type glycosylating enzyme polypeptide N-acetylgalactosaminyltransferase 14 promotes the migration of ovarian cancer by modifying mucin 13. , 2013, Oncology reports.

[22]  Jonathan C Trinidad,et al.  N- and O-Glycosylation in the Murine Synaptosome* , 2013, Molecular & Cellular Proteomics.

[23]  Uros Kuzmanov,et al.  Glycoproteomic identification of potential glycoprotein biomarkers in ovarian cancer proximal fluids , 2013, Clinical chemistry and laboratory medicine.

[24]  S. Brunak,et al.  Precision mapping of the human O‐GalNAc glycoproteome through SimpleCell technology , 2013, The EMBO journal.

[25]  Hannes Hahne,et al.  Proteome wide purification and identification of O-GlcNAc-modified proteins using click chemistry and mass spectrometry. , 2013, Journal of proteome research.

[26]  G. Larson,et al.  LC-MS/MS characterization of O-glycosylation sites and glycan structures of human cerebrospinal fluid glycoproteins. , 2013, Journal of proteome research.

[27]  M. Nowicki,et al.  Inhibitors of N-glycosylation as a potential tool for analysis of the mechanism of action and cellular localisation of glycoprotein P. , 2012, Acta biochimica Polonica.

[28]  S. Alouini.  Management of ovarian cancer has changed. , 2012, Gynecologic oncology.

[29]  Daniel Kolarich,et al.  Determination of site-specific glycan heterogeneity on glycoproteins , 2012, Nature Protocols.

[30]  L. Tabak,et al.  Control of mucin-type O-glycosylation: a classification of the polypeptide GalNAc-transferase gene family. , 2012, Glycobiology.

[31]  Li-ming Wang,et al.  Overexpression of catalytic subunit M2 in patients with ovarian cancer. , 2012, Chinese medical journal.

[32]  A. Burlingame,et al.  Global Identification and Characterization of Both O-GlcNAcylation and Phosphorylation at the Murine Synapse* , 2012, Molecular & Cellular Proteomics.

[33]  H. Wandall,et al.  Probing isoform-specific functions of polypeptide GalNAc-transferases using zinc finger nuclease glycoengineered SimpleCells , 2012, Proceedings of the National Academy of Sciences.

[34]  Matthew E Monroe,et al.  Tandem mass spectrometry identifies many mouse brain O-GlcNAcylated proteins including EGF domain-specific O-GlcNAc transferase targets , 2012, Proceedings of the National Academy of Sciences.

[35]  B. Monsarrat,et al.  Label-free Quantification and Shotgun Analysis of Complex Proteomes by One-dimensional SDS-PAGE/NanoLC-MS , 2012, Molecular & Cellular Proteomics.

[36]  Yuan Tian,et al.  Identification of glycoproteins associated with different histological subtypes of ovarian tumors using quantitative glycoproteomics , 2011, Proteomics.

[37]  Bin Zhang,et al.  PhosphoSitePlus: a comprehensive resource for investigating the structure and function of experimentally determined post-translational modifications in man and mouse , 2011, Nucleic Acids Res..

[38]  C. Bertozzi,et al.  Cell surface glycoproteomic analysis of prostate cancer-derived PC-3 cells. , 2011, Bioorganic & medicinal chemistry letters.

[39]  A. Jemal,et al.  Cancer statistics, 2011 , 2011, CA: a cancer journal for clinicians.

[40]  H. Hang,et al.  Chemical reporters for fluorescent detection and identification of O-GlcNAc-modified proteins reveal glycosylation of the ubiquitin ligase NEDD4-1 , 2011, Proceedings of the National Academy of Sciences.

[41]  Henrik Clausen,et al.  Location, location, location: new insights into O-GalNAc protein glycosylation. , 2011, Trends in cell biology.

[42]  M. Mann,et al.  Andromeda: a peptide search engine integrated into the MaxQuant environment. , 2011, Journal of proteome research.

[43]  Jennifer J. Kohler,et al.  Metabolic cross-talk allows labeling of O-linked β-N-acetylglucosamine-modified proteins via the N-acetylgalactosamine salvage pathway , 2011, Proceedings of the National Academy of Sciences.

[44]  Yuan Zhang,et al.  AEG -1 Overexpression: A Novel Indicator for Peritoneal Dissemination and Lymph Node Metastasis in Epithelial Ovarian Cancers , 2011, International Journal of Gynecologic Cancer.

[45]  Anne Dell,et al.  Similarities and Differences in the Glycosylation Mechanisms in Prokaryotes and Eukaryotes , 2011, International journal of microbiology.

[46]  W. Hancock,et al.  Technologies and strategies for glycoproteomics and glycomics and their application to clinical biomarker research. , 2011, Analytical methods : advancing methods and applications.

[47]  István Nagy,et al.  Quantitative proteome and transcriptome analysis of the archaeon Thermoplasma acidophilum cultured under aerobic and anaerobic conditions. , 2010, Journal of proteome research.

[48]  Yusuke Nakamura,et al.  Critical roles of mucin 1 glycosylation by transactivated polypeptide N-acetylgalactosaminyltransferase 6 in mammary carcinogenesis. , 2010, Cancer research.

[49]  T. Enomoto,et al.  Enhanced expression of Annexin A4 in clear cell carcinoma of the ovary and its association with chemoresistance to carboplatin , 2009, International journal of cancer.

[50]  L. Elsas,et al.  Galactose toxicity in animals , 2009, IUBMB life.

[51]  Carolyn R Bertozzi,et al.  Bioorthogonal chemistry: fishing for selectivity in a sea of functionality. , 2009, Angewandte Chemie.

[52]  Pixu Liu,et al.  Targeting the phosphoinositide 3-kinase pathway in cancer , 2009, Nature Reviews Drug Discovery.

[53]  M. Mann,et al.  MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification , 2008, Nature Biotechnology.

[54]  Chris Mungall,et al.  AmiGO: online access to ontology and annotation data , 2008, Bioinform..

[55]  E. Schuchman,et al.  Acid sphingomyelinase overexpression enhances the antineoplastic effects of irradiation in vitro and in vivo. , 2008, Molecular therapy : the journal of the American Society of Gene Therapy.

[56]  A. Perkins,et al.  Expression of MUC1 in primary and metastatic human epithelial ovarian cancer and its therapeutic significance. , 2007, Gynecologic oncology.

[57]  Mitchell Ho,et al.  Mesothelin-MUC16 binding is a high affinity, N-glycan dependent interaction that facilitates peritoneal metastasis of ovarian tumors , 2006, Molecular Cancer.

[58]  Ji Luo,et al.  The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism , 2006, Nature Reviews Genetics.

[59]  G. Hart,et al.  Cell signaling, the essential role of O-GlcNAc! , 2006, Biochimica et biophysica acta.

[60]  E. Martinelli,et al.  Class III β-Tubulin Overexpression Is a Marker of Poor Clinical Outcome in Advanced Ovarian Cancer Patients , 2006, Clinical Cancer Research.

[61]  J. Esko,et al.  The sweet and sour of cancer: glycans as novel therapeutic targets , 2005, Nature Reviews Cancer.

[62]  S. Brunak,et al.  Prediction, conservation analysis, and structural characterization of mammalian mucin-type O-glycosylation sites. , 2005, Glycobiology.

[63]  S. Ficarro,et al.  Exploring the O-GlcNAc proteome: direct identification of O-GlcNAc-modified proteins from the brain. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[64]  Chong Yu,et al.  A metabolic labeling approach toward proteomic analysis of mucin-type O-linked glycosylation , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[65]  S. Nozawa,et al.  Alteration in the metastatic potential of ovarian cancer cells by transfection of the antisense gene of beta-1,4-galactosyltransferase. , 2003, Oncology reports.

[66]  Carolyn R Bertozzi,et al.  A chemical approach for identifying O-GlcNAc-modified proteins in cells , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[67]  C. Bertozzi,et al.  Characterizing glycosylation pathways , 2001, Genome Biology.

[68]  R Apweiler,et al.  On the frequency of protein glycosylation, as deduced from analysis of the SWISS-PROT database. , 1999, Biochimica et biophysica acta.

[69]  J. Taylor‐Papadimitriou,et al.  MUC1 and cancer. , 1999, Biochimica et biophysica acta.

[70]  Y. Tashima,et al.  Expression of human beta 1,4-galactosyltransferase in gynecological cancer cell lines. , 1997, International journal of oncology.

[71]  R. W. Baldwin,et al.  Immunological and structural features of the protein core of human polymorphic epithelial mucin. , 1990, Molecular immunology.

[72]  D. Pennell,et al.  Symptomatic bradycardia complicating the use of intravenous dipyridamole for thallium-201 myocardial perfusion imaging. , 1990, International journal of cardiology.

[73]  I. Floriani,et al.  Conservative management of early-stage epithelial ovarian cancer: results of a large retrospective series. , 2013, Annals of oncology : official journal of the European Society for Medical Oncology.

[74]  K. Abbott.  Glycomic analysis of ovarian cancer: past, present, and future. , 2010, Cancer biomarkers : section A of Disease markers.

[75]  C. Bertozzi,et al.  Metabolic labeling of glycans with azido sugars and subsequent glycan-profiling and visualization via Staudinger ligation , 2007, Nature Protocols.

[76]  A. J. Parodi,et al.  Protein glucosylation and its role in protein folding. , 2000, Annual review of biochemistry.

[77]  B. Lentrichia,et al.  Biogenesis and content of rhodopsin in the retina of the chick during development. , 1988, Current eye research.